For this study, Best Practices engaged 22 leaders from 16 biopharmaceutical companies and two medical device and health care firms through a benchmarking survey.
Only a third of participants in the study said they had seen slight or great improvement of call quality since deploying iPads to MSLs; 57% said call quality has stayed the same.
A majority of study participants said there had been an increase in the number of scientific presentations delivered since the deployment of iPads to MSLs, according to the study.
Best Practices serves biopharmaceutical and medical device companies worldwide. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software
Tristel secures FDA clearance for Ophthalmic Disinfectant Tristel OPH